Prescription Drug: Pricing

Administration Withdraws Rebate Overhaul Proposal

The Administration has announced it is no longer pursuing its drug pricing proposal that would have required pharmacy benefit managers to pass rebates directly on to the patient.

POST

• drug pricing /
• Medicaid /
• Medicare /
• Part D /
• PBM /
• rebate

Prescription Drug: Pricing

House E&C Health Subcommittee to Hold Medicare Prescription Drug Cost Hearing

The House Energy and Commerce Health Subcommittee will hold a hearing on prescription drug costs in Medicare. Drug pricing continues to be a hot topic on Capitol Hill as lawmakers review several proposals to lower costs.

EXTERNAL LINK

• cost /
• Hearing /
• prescription drugs

Prescription Drug: Pricing , Regulation

Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses

EXTERNAL LINK

• MA /
• Part D /
• Proposed Rule

Prescription Drug: Pricing , Regulation

ANPRM IPI Model for Medicare Part B Drugs

EXTERNAL LINK

• Blueprint /
• IPI /
• Part B

Prescription Drug: Pricing , Regulation

Regulation to Require Drug Pricing Transparency

EXTERNAL LINK

• CMS /
• HHS /
• Proposed Rule